What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Nephro Care India Limited IPO?

Based on the upper price band of ₹90 and current GMP of ₹175, the estimated listing price is ₹265 (approx. 194.4% gain).

What is the expected profit per lot for Nephro Care India Limited IPO?

With a lot size of 1600 shares and current GMP of ₹175, expected profit per retail application lot is approximately ₹2,80,000.

IPO GreyPremiumLIVE

Grey Market Intelligence

Nephro Care India Limited

ListedSME

Healthcare · NSE

Nephro Care India Limited, incorporated in 2014 and based in Kolkata, is a specialized treatment center focusing on renal insufficiency and comprehensive clinical and lifestyle solutions. Supported by expert doctors, paramedical professionals, and a skilled management team, the hospital serves approximately 900 Chronic Kidney Disease patients monthly. Operating from a 5,352 sq. ft. main clinic in Salt Lake and three satellite clinics in Salt Lake (HB 113) and Chandannagar, West Bengal, Nephro Care employs 110 staff members, including 5 permanent doctors, 10 visiting consultants, and 70 paramedical professionals. The center offers a wide range of services, including an in-house Dialysis Unit, outpatient services in nephrology, diabetology, cardiology, ophthalmology, and neurology, an NABL-accredited in-house pathology, a pharmacy, advanced diagnostics, a renal nutrition department, home care, the Mukti Lifestyle Support Program, and home dialysis services.

Price Band

₹85 – ₹90

Issue Size

₹41.26 Cr

Lot Size

1600 shares

GMP

₹175

+194.4%

Est. Listing

₹265

at current GMP

Subscribed

770.15x

overall

Open

28 Jun 2024

2 Jul 2024

Allotment

3 Jul 2024

Refund

4 Jul 2024

Demat Credit

5 Jul 2024

Listing

5 Jul 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Nephro Care India Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹175+194.4%

Issue Price (Upper)

₹90

Band: ₹85 – ₹90

Estimated Listing Price

₹265

Upper price + GMP

Lot Size

1600 shares

Min investment ₹1,44,000

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹175	194.4%	₹265
30 Oct 2026	+₹175	194.4%	₹265
29 Oct 2026	+₹158	175.0%	₹248

About Nephro Care India Limited Public Issue & Market Profile

Nephro Care India Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹41.26 Crores. The shares are offered at a price band of ₹85 to ₹90 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Public Issue & Pricing Context:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Basis of Allotment & Listing Timeline:

Following the close of bidding on 2024-07-02, the basis of allotment is scheduled to be finalized on 2024-07-03. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Nephro Care India Limited IPO GMP today?

The latest grey market premium for Nephro Care India Limited IPO is ₹175, which indicates an expected listing price of ₹265.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.